Trial Type: Other Hematology

BH-P-CEDER
A Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of NDI-219216 in Patients With Advanced Solid Tumors With/Without Microsatellite Instability and/or Deficient Mismatch Repair
Protocol Status: OPEN TO ACCRUAL
Trial Type: Breast, Endocrine Neuroendocrine, Gastrointestinal, Genitourinary, Gynecologic, Head and Neck, Musculoskeletal, Neurologic, Other Hematology, Skin, Thoracic
Contact: Carneiro, Benedito
benedito.carneiro@BrownHealth.org
BH-P-LUMINA-3
A Multicenter, Open-label, Phase IIb Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (LUMINA 2)
Protocol Status: OPEN TO ACCRUAL
Trial Type: Other Hematology
Contact: Hsu, Andrew
ahsu2@BrownHealth.org
ALTE2131
Triptorelin and Protection of Ovarian Reserve in Adolescents and Young Adults With Cancer
Protocol Status: OPEN TO ACCRUAL
Trial Type: Eye, Gastrointestinal, Genitourinary, Leukemia, Lymphoma, Musculoskeletal, Neurologic, Other Hematology, Skin, Unknown Primary
Contact: DeNardo, Bradley
bdenardo@BrownHealth.org